Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer  Earl Gillespie, Susan E. Leeman,

Slides:



Advertisements
Similar presentations
Major Action of Endogenous Lysyl Oxidase in Clear Cell Renal Cell Carcinoma Progression and Collagen Stiffness Revealed by Primary Cell Cultures  Vitalba.
Advertisements

Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy  Dina Chelouche-Lev, Claudia P. Miller, Carmen.
Disseminated Cryptococcus neoformans infection and Crohn's disease in an immunocompetent patient  Guido Sciaudone, Gianluca Pellino, Ilaria Guadagni,
Volume 355, Issue 2, Pages (December 2014)
Leigh A. Beamish, Alvaro R. Osornio-Vargas, Eytan Wine 
Angiogenesis and hepatocellular carcinoma
Hon-Wai Koon, Dezheng Zhao, Hua Xu, Collin Bowe, Alan Moss, Mary P
Association of a Nkx2-3 polymorphism with Crohn's disease and expression of Nkx2-3 is up-regulated in B cell lines and intestinal tissues with Crohn's.
Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease  Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim  Journal.
Volume 40, Issue 1, Pages 1-2 (January 2014)
Volume 15, Issue 6, Pages (June 2009)
W. Dolak, J. Maresch, F. Kainberger, F. Wrba, Ch. Müller 
Anti-Aging Therapy With Human Growth Hormone Associated With Metastatic Colon Cancer in a Patient With Crohn’s Colitis  Gil Y. Melmed, Shane M. Devlin,
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Inflammation and Colon Cancer
Volume 85, Issue 2, Pages (January 2014)
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-EGFR and Anti-MET Therapies  Sandra Salvi, PhD, Serena Varesano, PhD, Simona.
Volume 85, Issue 2, Pages (January 2014)
Volume 76, Issue 1, Pages (July 2009)
IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling  Yuan-Hua Xu, Zheng-Li Li,
Volume 132, Issue 1, Pages (January 2007)
Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner  A. Bianchi, M. Guibert, F. Cailotto,
X. Zhang, I. Prasadam, W. Fang, R. Crawford, Y. Xiao 
Management of advanced renal cancer
Volume 133, Issue 6, Pages (December 2007)
Microvascular responses to sepsis: clinical significance
Volume 85, Issue 2, Pages (January 2014)
Targeted Overexpression of the Angiogenesis Inhibitor Thrombospondin-1 in the Epidermis of Transgenic Mice Prevents Ultraviolet-B-Induced Angiogenesis.
Volume 115, Issue 2, Pages (August 1998)
Learning More from Microarrays: Insights from Modules and Networks
Volume 133, Issue 6, Pages e1 (December 2007)
Pediatric pulmonary Crohn's disease: More frequent than expected
Pathogenic Escherichia coli in inflammatory bowel diseases
Volume 61, Issue 5, Pages (May 2002)
Volume 42, Issue 4, Pages (April 2005)
TGF-β isoforms in renal fibrogenesis
Association of a Nkx2-3 polymorphism with Crohn's disease and expression of Nkx2-3 is up-regulated in B cell lines and intestinal tissues with Crohn's.
Volume 6, Issue 2, Pages (August 2002)
Loss of EPC-1/PEDF Expression During Skin Aging In Vivo
Volume 6, Issue 3, Pages (September 2004)
Volume 29, Issue 4, Pages (April 2016)
Angiogenesis and hepatocellular carcinoma
P16Ink4a Suppression of Lung Adenocarcinoma by Bmi-1 in the Presence of p38 Activation  Mi-Ok Lee, MSc, Hyeon-Jae Lee, MD, Mi-Ae Kim, MD, Eun-Kyung Kim,
Mechanisms of Action of Etanercept in Psoriasis
Volume 79, Issue 7, Pages (April 2011)
Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma
Volume 7, Issue 2, Pages (February 2010)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Activin A Is Anti-Lymphangiogenic in a Melanoma Mouse Model
Regulation of Fibulin-2 Gene Expression by Integrin α3β1 Contributes to the Invasive Phenotype of Transformed Keratinocytes  Dara S. Missan, Sridar V.
Volume 75, Issue 8, Pages (April 2009)
Volume 80, Issue 12, Pages (December 2011)
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Volume 19, Issue 13, Pages (June 2017)
Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis  Giuseppina A.
Increased Vascular-Endothelial Growth Factor (VEGF) Tumor Expression and Response to Epidermal Growth Factor Receptor (EGF-R) Inhibitor Erlotinib in Non-small.
Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non- small Cell Lung Cancer  Tomofumi Yohena, MD, Ichiro Yoshino, MD,
Volume 59, Issue 2, Pages (August 2013)
Tej Pratap Singh, Gerlinde Mayer, Peter Wolf 
SRC and STAT Pathways Journal of Thoracic Oncology
Volume 76, Issue 7, Pages (October 2009)
Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma
Endothelial Cells Form a Phalanx to Block Tumor Metastasis
Volume 63, Issue 5, Pages (May 2003)
Jun Asai, Hideya Takenaka, Norito Katoh, Saburo Kishimoto 
Volume 41, Issue 5, Pages (November 2004)
Intratumoral hypoxia, radiation resistance, and HIF-1
Aldo-Keto Reductase 1C3 Is Expressed in Differentiated Human Epidermis, Affects Keratinocyte Differentiation, and Is Upregulated in Atopic Dermatitis 
Volume 1, Issue 2, Pages (August 2007)
Volume 75, Issue 8, Pages (April 2009)
Presentation transcript:

Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer  Earl Gillespie, Susan E. Leeman, Luisa A. Watts, Jennifer A. Coukos, Michael J. O'Brien, Sandra R. Cerda, Francis A. Farraye, Arthur F. Stucchi  Journal of Crohn's and Colitis  Volume 7, Issue 5, Pages 403-411 (June 2013) DOI: 10.1016/j.crohns.2012.08.003 Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 1 Hematoxylin and eosin stained sections from colitis-associated cancer patients. Bright field photomicrographs from colon section displaying quiescent colitis at (A) 100× and (B) 200× magnification showing branched and elongated crypts typical of reparative processes after inflammation; high-grade dysplasia at (C) 100× and (D) 200× magnification; and carcinoma at (E) 40× and (F) 100× magnification. In high-grade dysplasia, note the increased size and disorder of the nuclei (D, indicated by arrows). In carcinoma, note the invasive pseudo-crypts that extend beyond the mucosal membrane (E, indicated by arrows). Journal of Crohn's and Colitis 2013 7, 403-411DOI: (10.1016/j.crohns.2012.08.003) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 2 mRNA expression of SERPINE1 is increased in the transition from quiescent colitis to carcinoma. Each group (n=5) contains individual observations (each individual is a distinct color/shape) and means±SEM for groups. Results were calculated using the ΔΔCt method and expressed as a fold change of the quiescent colitis group as described in the RT2 Profiler™ PCR Array Data Analysis (http://www.sabiosciences.com/pcrarraydataanalysis.php). Journal of Crohn's and Colitis 2013 7, 403-411DOI: (10.1016/j.crohns.2012.08.003) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 3 Protein levels of PAI-1 are increased in the transition from quiescent colitis to high grade dysplasia and carcinoma. Representative images immunofluorescent staining of quiescent epithelium (top left), high-grade dysplasia (middle left) and carcinoma (bottom left) using an antibody targeting PAI-1. Exposure time=300msec. Top right, mean fluorescent intensities with individual observations (each individual is a distinct color/shape) and mean±SEM (n=11 quiescent colitis, n=10 high-grade dysplasia, n=9 carcinoma). Each observation represents the average fluorescent intensity from five randomly selected fields. *p<0.05 compared to quiescent colitis. Bottom right, staining without (left) and with (right) neutralizing peptide displays specificity of the antibody. Journal of Crohn's and Colitis 2013 7, 403-411DOI: (10.1016/j.crohns.2012.08.003) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 4 mRNA expression of genes that regulate PAI-1 is increased in the transition from non-neoplastic epithelium to carcinoma. Graphs for NKFB2, REL, SRC and VEGFA with individual observations (each patient is a distinct color/shape) with means±SEM. Results were calculated using the ΔΔCt method and expressed as a fold change of the quiescent colitis group as described in the RT2 Profiler™ PCR Array Data Analysis (http://www.sabiosciences.com/pcrarraydataanalysis.php). *p<0.05 difference between groups. Journal of Crohn's and Colitis 2013 7, 403-411DOI: (10.1016/j.crohns.2012.08.003) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 5 Pathways by which PAI-1 may contribute to colitis-associated cancer. Here we propose a mechanism by which an epithelial cell responds to the stimuli present in chronic inflammation by upregulating PAI-1 and some pro-malignant sequelae of that upregulation. Inflammation produces a variety of signals that can upregulate PAI-1 in colitis-associated cancer; these signals include oxidative stress, inflammatory mediators, hypoxia, and substance P. We have shown that both isoforms of the neurokinin-1 receptor are expressed in colon epithelial cells and that the truncated form is increased in dysplasia and colitis-associated cancer.17 The upregulation of PAI-1 has direct consequences for the epithelial cell that promote its transformation to dysplasia or malignancy, including anti-apoptotic signaling and the promotion of angiogenesis and cell motility and metastasis. Additionally, transformed cells may be capable of producing signals that upregulate PAI-1. Genes depicted in bold/red were also identified as increased in this study. Abbreviations: RONS, reactive oxygen and nitrogen species; SP, substance P; HIF, hypoxia inducible factor; NF-κB, nuclear factor kappa B; PAI, plasminogen activator inhibitor; VEGF, vascular endothelial growth factor. Journal of Crohn's and Colitis 2013 7, 403-411DOI: (10.1016/j.crohns.2012.08.003) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions